News &amp; Updates

Do hormonal contraceptives raise CRC risk in premenopausal women?

28 Jul 2026 by

The use of combined oral contraceptives, progestogen-only pills, or hormonal intrauterine devices neither protects against nor contributes to the risk of colorectal cancer (CRC) in premenopausal women, according to a study.

Do hormonal contraceptives raise CRC risk in premenopausal women?

28 Jul 2026

Topical on par with systemic corticosteroids for DRESS syndrome

A recent study has shown no significant differences in outcomes between initial topical and systemic corticosteroid therapy among patients with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.

Topical on par with systemic corticosteroids for DRESS syndrome

Add-on sirolimus shows promise across multiple endpoints in SLE

28 Jul 2026 by

Adding sirolimus to standard-of-care (SoC) significantly improves clinical and serological outcomes in patients with active systemic lupus erythematosus (SLE), according to the SIRIUS* trial presented at EULAR 2026.

Add-on sirolimus shows promise across multiple endpoints in SLE

Fish oil plus low-dose isotretinoin shows promise as acne vulgaris therapy

The combination of fish oil supplementation and low-dose isotretinoin demonstrates noninferiority to isotretinoin monotherapy and keeps the skin hydrated in patients with moderate-to-severe acne vulgaris, reports a study. The combined treatment also helps control triglyceride levels.

Fish oil plus low-dose isotretinoin shows promise as acne vulgaris therapy

Which anti-obesity drug is safest, most effective?

27 Jul 2026 by

Among available drugs for obesity, tirzepatide and cagrilintide-semaglutide (CagriSema) yield the largest decrease in body weight, regardless of diabetes status, suggest the results of a systematic review and network meta-analysis.

Which anti-obesity drug is safest, most effective?

27 Jul 2026

Cefdinir vs cephalexin: Which is a better step-down therapy in severe UTI?

Treatment with cefdinir and cephalexin results in comparable failure rates, but patients on cephalexin tend to have more unplanned clinic and emergency visits, a study has shown.

Cefdinir vs cephalexin: Which is a better step-down therapy in severe UTI?

Original New Drug Application Approvals by US FDA (1-15 July 2026)

New drug applications approved by US FDA as of 1-15 July 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 July 2026)

Buprenorphine a viable option for acute pain in ICU patients

The use of intravenous (IV) buprenorphine appears to be a good substitute for full agonist IV opioids for managing pain in the medical intensive care unit (ICU), suggests a study.

Buprenorphine a viable option for acute pain in ICU patients

Lithium use during pregnancy ups risk of preterm birth

Pregnant women who are using lithium are at increased risk of spontaneous preterm birth, according to a retrospective study.

Lithium use during pregnancy ups risk of preterm birth